nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Lomustine—brain cancer	0.122	0.263	CbGbCtD
Fingolimod—CYP2D6—Hydroxyurea—brain cancer	0.0923	0.199	CbGbCtD
Fingolimod—CYP3A4—Temozolomide—brain cancer	0.091	0.197	CbGbCtD
Fingolimod—CYP3A4—Lomustine—brain cancer	0.0774	0.167	CbGbCtD
Fingolimod—CYP2E1—Etoposide—brain cancer	0.0617	0.133	CbGbCtD
Fingolimod—CYP3A4—Etoposide—brain cancer	0.0187	0.0404	CbGbCtD
Fingolimod—S1PR1—ganglion—brain cancer	0.0138	0.0763	CbGeAlD
Fingolimod—Herpes NOS—Procarbazine—brain cancer	0.0135	0.103	CcSEcCtD
Fingolimod—S1PR1—endothelium—brain cancer	0.0119	0.0658	CbGeAlD
Fingolimod—S1PR1—blood vessel—brain cancer	0.0109	0.0607	CbGeAlD
Fingolimod—Herpes virus infection—Procarbazine—brain cancer	0.00929	0.0711	CcSEcCtD
Fingolimod—S1PR1—brainstem—brain cancer	0.00598	0.0332	CbGeAlD
Fingolimod—S1PR4—endocrine gland—brain cancer	0.00544	0.0302	CbGeAlD
Fingolimod—S1PR1—telencephalon—brain cancer	0.00531	0.0294	CbGeAlD
Fingolimod—S1PR5—midbrain—brain cancer	0.0052	0.0288	CbGeAlD
Fingolimod—S1PR3—gonad—brain cancer	0.00502	0.0279	CbGeAlD
Fingolimod—S1PR5—endocrine gland—brain cancer	0.00457	0.0253	CbGeAlD
Fingolimod—S1PR5—head—brain cancer	0.00451	0.025	CbGeAlD
Fingolimod—SPHK1—gonad—brain cancer	0.00438	0.0243	CbGeAlD
Fingolimod—CYP4F2—endocrine gland—brain cancer	0.00428	0.0237	CbGeAlD
Fingolimod—SPHK1—pituitary gland—brain cancer	0.00428	0.0237	CbGeAlD
Fingolimod—CYP4F2—head—brain cancer	0.00423	0.0234	CbGeAlD
Fingolimod—Traumatic liver injury—Temozolomide—brain cancer	0.00419	0.032	CcSEcCtD
Fingolimod—S1PR5—central nervous system—brain cancer	0.00412	0.0228	CbGeAlD
Fingolimod—CYP4F12—pituitary gland—brain cancer	0.00411	0.0228	CbGeAlD
Fingolimod—S1PR5—cerebellum—brain cancer	0.00402	0.0223	CbGeAlD
Fingolimod—CYP4F12—medulla oblongata—brain cancer	0.00396	0.022	CbGeAlD
Fingolimod—S1PR1—midbrain—brain cancer	0.00381	0.0211	CbGeAlD
Fingolimod—S1PR3—endocrine gland—brain cancer	0.0038	0.0211	CbGeAlD
Fingolimod—SPHK1—midbrain—brain cancer	0.00377	0.0209	CbGeAlD
Fingolimod—S1PR3—head—brain cancer	0.00375	0.0208	CbGeAlD
Fingolimod—S1PR1—spinal cord—brain cancer	0.00372	0.0206	CbGeAlD
Fingolimod—CYP4F12—midbrain—brain cancer	0.00362	0.0201	CbGeAlD
Fingolimod—CYP4F12—spinal cord—brain cancer	0.00354	0.0196	CbGeAlD
Fingolimod—S1PR3—central nervous system—brain cancer	0.00342	0.019	CbGeAlD
Fingolimod—S1PR1—endocrine gland—brain cancer	0.00335	0.0186	CbGeAlD
Fingolimod—SPHK1—endocrine gland—brain cancer	0.00331	0.0184	CbGeAlD
Fingolimod—S1PR1—head—brain cancer	0.00331	0.0183	CbGeAlD
Fingolimod—S1PR5—brain—brain cancer	0.00327	0.0181	CbGeAlD
Fingolimod—CYP4F12—endocrine gland—brain cancer	0.00318	0.0176	CbGeAlD
Fingolimod—Lymphopenia—Temozolomide—brain cancer	0.00305	0.0233	CcSEcCtD
Fingolimod—S1PR1—central nervous system—brain cancer	0.00302	0.0167	CbGeAlD
Fingolimod—S1PR1—cerebellum—brain cancer	0.00295	0.0163	CbGeAlD
Fingolimod—Cerebral haemorrhage—Carmustine—brain cancer	0.00291	0.0223	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Temozolomide—brain cancer	0.00282	0.0215	CcSEcCtD
Fingolimod—CYP4F12—cerebellum—brain cancer	0.0028	0.0155	CbGeAlD
Fingolimod—S1PR3—brain—brain cancer	0.00272	0.0151	CbGeAlD
Fingolimod—Visual acuity reduced—Temozolomide—brain cancer	0.00262	0.0201	CcSEcCtD
Fingolimod—S1PR1—brain—brain cancer	0.0024	0.0133	CbGeAlD
Fingolimod—SPHK1—brain—brain cancer	0.00237	0.0131	CbGeAlD
Fingolimod—CYP4F12—brain—brain cancer	0.00228	0.0126	CbGeAlD
Fingolimod—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00211	0.0161	CcSEcCtD
Fingolimod—Herpes zoster—Temozolomide—brain cancer	0.00207	0.0158	CcSEcCtD
Fingolimod—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.0019	0.0145	CcSEcCtD
Fingolimod—Liver injury—Temozolomide—brain cancer	0.00185	0.0142	CcSEcCtD
Fingolimod—Alopecia—Lomustine—brain cancer	0.0018	0.0138	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Temozolomide—brain cancer	0.00165	0.0126	CcSEcCtD
Fingolimod—Infection—Carboplatin—brain cancer	0.00165	0.0126	CcSEcCtD
Fingolimod—Leukopenia—Lomustine—brain cancer	0.00159	0.0122	CcSEcCtD
Fingolimod—Pneumonia—Procarbazine—brain cancer	0.00145	0.0111	CcSEcCtD
Fingolimod—Infection—Lomustine—brain cancer	0.00144	0.011	CcSEcCtD
Fingolimod—CYP2D6—hindbrain—brain cancer	0.00132	0.00734	CbGeAlD
Fingolimod—Eye pain—Carmustine—brain cancer	0.0013	0.00993	CcSEcCtD
Fingolimod—Gastroenteritis—Temozolomide—brain cancer	0.00128	0.00977	CcSEcCtD
Fingolimod—Eye pain—Temozolomide—brain cancer	0.00125	0.00959	CcSEcCtD
Fingolimod—Alopecia—Procarbazine—brain cancer	0.00114	0.00876	CcSEcCtD
Fingolimod—Infestation—Hydroxyurea—brain cancer	0.00112	0.00854	CcSEcCtD
Fingolimod—Infestation NOS—Hydroxyurea—brain cancer	0.00112	0.00854	CcSEcCtD
Fingolimod—Liver function test abnormal—Carmustine—brain cancer	0.00108	0.00827	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00102	0.0078	CcSEcCtD
Fingolimod—Leukopenia—Procarbazine—brain cancer	0.00101	0.00772	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000998	0.00764	CcSEcCtD
Fingolimod—Cough—Procarbazine—brain cancer	0.000984	0.00753	CcSEcCtD
Fingolimod—Hypertension—Procarbazine—brain cancer	0.000973	0.00745	CcSEcCtD
Fingolimod—Bronchitis—Temozolomide—brain cancer	0.000941	0.0072	CcSEcCtD
Fingolimod—Infection—Procarbazine—brain cancer	0.000914	0.00699	CcSEcCtD
Fingolimod—Angiopathy—Hydroxyurea—brain cancer	0.000909	0.00696	CcSEcCtD
Fingolimod—Pneumonia—Carmustine—brain cancer	0.000908	0.00695	CcSEcCtD
Fingolimod—Depression—Carmustine—brain cancer	0.0009	0.00689	CcSEcCtD
Fingolimod—Alopecia—Hydroxyurea—brain cancer	0.000886	0.00678	CcSEcCtD
Fingolimod—Weight decreased—Temozolomide—brain cancer	0.000885	0.00677	CcSEcCtD
Fingolimod—Pneumonia—Temozolomide—brain cancer	0.000877	0.00671	CcSEcCtD
Fingolimod—Infestation NOS—Temozolomide—brain cancer	0.000872	0.00667	CcSEcCtD
Fingolimod—Infestation—Temozolomide—brain cancer	0.000872	0.00667	CcSEcCtD
Fingolimod—Depression—Temozolomide—brain cancer	0.00087	0.00665	CcSEcCtD
Fingolimod—Cardiac arrest—Etoposide—brain cancer	0.000861	0.00659	CcSEcCtD
Fingolimod—Hypotension—Procarbazine—brain cancer	0.00086	0.00658	CcSEcCtD
Fingolimod—CYP2E1—telencephalon—brain cancer	0.000851	0.00472	CbGeAlD
Fingolimod—Paraesthesia—Procarbazine—brain cancer	0.000826	0.00632	CcSEcCtD
Fingolimod—Sinusitis—Temozolomide—brain cancer	0.000818	0.00626	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Etoposide—brain cancer	0.000799	0.00611	CcSEcCtD
Fingolimod—Connective tissue disorder—Carmustine—brain cancer	0.000796	0.00609	CcSEcCtD
Fingolimod—Fatigue—Procarbazine—brain cancer	0.000793	0.00607	CcSEcCtD
Fingolimod—Leukopenia—Hydroxyurea—brain cancer	0.000781	0.00598	CcSEcCtD
Fingolimod—Connective tissue disorder—Temozolomide—brain cancer	0.00077	0.00589	CcSEcCtD
Fingolimod—CYP2D6—brainstem—brain cancer	0.000759	0.00421	CbGeAlD
Fingolimod—Eye disorder—Carmustine—brain cancer	0.000757	0.00579	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000738	0.00564	CcSEcCtD
Fingolimod—Eye disorder—Temozolomide—brain cancer	0.000732	0.0056	CcSEcCtD
Fingolimod—Cardiac disorder—Temozolomide—brain cancer	0.000727	0.00556	CcSEcCtD
Fingolimod—Alopecia—Carmustine—brain cancer	0.000716	0.00548	CcSEcCtD
Fingolimod—Angiopathy—Temozolomide—brain cancer	0.00071	0.00544	CcSEcCtD
Fingolimod—Mental disorder—Carmustine—brain cancer	0.00071	0.00543	CcSEcCtD
Fingolimod—Infection—Hydroxyurea—brain cancer	0.000707	0.00541	CcSEcCtD
Fingolimod—Mediastinal disorder—Temozolomide—brain cancer	0.000706	0.0054	CcSEcCtD
Fingolimod—Pneumonia—Etoposide—brain cancer	0.000702	0.00537	CcSEcCtD
Fingolimod—Nervous system disorder—Hydroxyurea—brain cancer	0.000698	0.00534	CcSEcCtD
Fingolimod—Infestation NOS—Etoposide—brain cancer	0.000698	0.00534	CcSEcCtD
Fingolimod—Infestation—Etoposide—brain cancer	0.000698	0.00534	CcSEcCtD
Fingolimod—Alopecia—Temozolomide—brain cancer	0.000692	0.00529	CcSEcCtD
Fingolimod—Skin disorder—Hydroxyurea—brain cancer	0.000692	0.00529	CcSEcCtD
Fingolimod—Mental disorder—Temozolomide—brain cancer	0.000686	0.00525	CcSEcCtD
Fingolimod—Back pain—Carmustine—brain cancer	0.000682	0.00522	CcSEcCtD
Fingolimod—CYP2D6—telencephalon—brain cancer	0.000674	0.00374	CbGeAlD
Fingolimod—CYP2E1—medulla oblongata—brain cancer	0.000669	0.00371	CbGeAlD
Fingolimod—Vision blurred—Carmustine—brain cancer	0.000665	0.00509	CcSEcCtD
Fingolimod—Asthenia—Procarbazine—brain cancer	0.00066	0.00505	CcSEcCtD
Fingolimod—Back pain—Temozolomide—brain cancer	0.000659	0.00504	CcSEcCtD
Fingolimod—Pruritus—Procarbazine—brain cancer	0.000651	0.00498	CcSEcCtD
Fingolimod—Vision blurred—Temozolomide—brain cancer	0.000642	0.00492	CcSEcCtD
Fingolimod—Dyspnoea—Hydroxyurea—brain cancer	0.000635	0.00486	CcSEcCtD
Fingolimod—Leukopenia—Carmustine—brain cancer	0.000631	0.00483	CcSEcCtD
Fingolimod—Diarrhoea—Procarbazine—brain cancer	0.00063	0.00482	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000615	0.0047	CcSEcCtD
Fingolimod—Fatigue—Hydroxyurea—brain cancer	0.000614	0.0047	CcSEcCtD
Fingolimod—Leukopenia—Temozolomide—brain cancer	0.00061	0.00467	CcSEcCtD
Fingolimod—Hypertension—Carmustine—brain cancer	0.000609	0.00466	CcSEcCtD
Fingolimod—Dizziness—Procarbazine—brain cancer	0.000608	0.00466	CcSEcCtD
Fingolimod—Palpitations—Temozolomide—brain cancer	0.000602	0.00461	CcSEcCtD
Fingolimod—CYP2E1—spinal cord—brain cancer	0.000596	0.00331	CbGeAlD
Fingolimod—Cough—Temozolomide—brain cancer	0.000595	0.00455	CcSEcCtD
Fingolimod—Hypertension—Temozolomide—brain cancer	0.000589	0.0045	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—brain cancer	0.000586	0.00448	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—brain cancer	0.000582	0.00445	CcSEcCtD
Fingolimod—Headache—Procarbazine—brain cancer	0.000576	0.00441	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000576	0.00441	CcSEcCtD
Fingolimod—Infection—Carmustine—brain cancer	0.000572	0.00438	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—brain cancer	0.000569	0.00435	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—brain cancer	0.000565	0.00432	CcSEcCtD
Fingolimod—Alopecia—Etoposide—brain cancer	0.000554	0.00424	CcSEcCtD
Fingolimod—Infection—Temozolomide—brain cancer	0.000553	0.00423	CcSEcCtD
Fingolimod—Nervous system disorder—Temozolomide—brain cancer	0.000546	0.00417	CcSEcCtD
Fingolimod—Skin disorder—Temozolomide—brain cancer	0.00054	0.00413	CcSEcCtD
Fingolimod—Hypotension—Carmustine—brain cancer	0.000538	0.00412	CcSEcCtD
Fingolimod—CYP2E1—endocrine gland—brain cancer	0.000537	0.00298	CbGeAlD
Fingolimod—CYP2E1—head—brain cancer	0.00053	0.00294	CbGeAlD
Fingolimod—Back pain—Etoposide—brain cancer	0.000528	0.00404	CcSEcCtD
Fingolimod—Paraesthesia—Carmustine—brain cancer	0.000517	0.00396	CcSEcCtD
Fingolimod—Dyspnoea—Carmustine—brain cancer	0.000513	0.00393	CcSEcCtD
Fingolimod—Asthenia—Hydroxyurea—brain cancer	0.000511	0.00391	CcSEcCtD
Fingolimod—Paraesthesia—Temozolomide—brain cancer	0.0005	0.00382	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Carmustine—brain cancer	0.000497	0.0038	CcSEcCtD
Fingolimod—Dyspnoea—Temozolomide—brain cancer	0.000496	0.00379	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—brain cancer	0.000488	0.00374	CcSEcCtD
Fingolimod—Diarrhoea—Hydroxyurea—brain cancer	0.000487	0.00373	CcSEcCtD
Fingolimod—CYP2E1—central nervous system—brain cancer	0.000484	0.00268	CbGeAlD
Fingolimod—Gastrointestinal disorder—Temozolomide—brain cancer	0.00048	0.00367	CcSEcCtD
Fingolimod—Fatigue—Temozolomide—brain cancer	0.00048	0.00367	CcSEcCtD
Fingolimod—Cough—Etoposide—brain cancer	0.000476	0.00364	CcSEcCtD
Fingolimod—CYP2E1—cerebellum—brain cancer	0.000473	0.00262	CbGeAlD
Fingolimod—Hypertension—Etoposide—brain cancer	0.000471	0.0036	CcSEcCtD
Fingolimod—Dizziness—Hydroxyurea—brain cancer	0.000471	0.0036	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000461	0.00353	CcSEcCtD
Fingolimod—Headache—Hydroxyurea—brain cancer	0.000446	0.00341	CcSEcCtD
Fingolimod—Infection—Etoposide—brain cancer	0.000442	0.00338	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—brain cancer	0.000432	0.00331	CcSEcCtD
Fingolimod—CYP3A4—endocrine gland—brain cancer	0.000432	0.00239	CbGeAlD
Fingolimod—S1PR5—Signaling Pathways—PTCH2—brain cancer	0.000426	0.00188	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTCH2—brain cancer	0.000426	0.00188	CbGpPWpGaD
Fingolimod—CYP2D6—endocrine gland—brain cancer	0.000425	0.00236	CbGeAlD
Fingolimod—CYP4F2—Metabolism—CYP2C9—brain cancer	0.000424	0.00188	CbGpPWpGaD
Fingolimod—CYP2D6—head—brain cancer	0.00042	0.00233	CbGeAlD
Fingolimod—CYP4F12—Metabolism—BSG—brain cancer	0.000418	0.00185	CbGpPWpGaD
Fingolimod—Hypotension—Etoposide—brain cancer	0.000416	0.00318	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—STRADA—brain cancer	0.000416	0.00184	CbGpPWpGaD
Fingolimod—Asthenia—Carmustine—brain cancer	0.000413	0.00316	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—HES5—brain cancer	0.000412	0.00182	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HES5—brain cancer	0.000412	0.00182	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—TRPC6—brain cancer	0.000409	0.00181	CbGpPWpGaD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—MYC—brain cancer	0.000401	0.00178	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STRADA—brain cancer	0.0004	0.00177	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STRADA—brain cancer	0.0004	0.00177	CbGpPWpGaD
Fingolimod—Paraesthesia—Etoposide—brain cancer	0.0004	0.00306	CcSEcCtD
Fingolimod—Asthenia—Temozolomide—brain cancer	0.000399	0.00305	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—brain cancer	0.000397	0.00304	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—TRPC6—brain cancer	0.000394	0.00174	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—TRPC6—brain cancer	0.000394	0.00174	CbGpPWpGaD
Fingolimod—Diarrhoea—Carmustine—brain cancer	0.000394	0.00301	CcSEcCtD
Fingolimod—Pruritus—Temozolomide—brain cancer	0.000394	0.00301	CcSEcCtD
Fingolimod—CYP3A4—central nervous system—brain cancer	0.000389	0.00216	CbGeAlD
Fingolimod—S1PR1—Signaling Pathways—PTCH2—brain cancer	0.000386	0.00171	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SHH—brain cancer	0.000386	0.00171	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Etoposide—brain cancer	0.000384	0.00294	CcSEcCtD
Fingolimod—CYP2E1—brain—brain cancer	0.000384	0.00213	CbGeAlD
Fingolimod—Fatigue—Etoposide—brain cancer	0.000384	0.00294	CcSEcCtD
Fingolimod—CYP2D6—central nervous system—brain cancer	0.000383	0.00212	CbGeAlD
Fingolimod—Dizziness—Carmustine—brain cancer	0.000381	0.00291	CcSEcCtD
Fingolimod—Diarrhoea—Temozolomide—brain cancer	0.000381	0.00291	CcSEcCtD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000377	0.00167	CbGpPWpGaD
Fingolimod—CYP2D6—cerebellum—brain cancer	0.000374	0.00208	CbGeAlD
Fingolimod—S1PR1—Signaling Pathways—HES5—brain cancer	0.000374	0.00166	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000372	0.00165	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—TRPC6—brain cancer	0.000372	0.00164	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—SHH—brain cancer	0.000371	0.00164	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SHH—brain cancer	0.000371	0.00164	CbGpPWpGaD
Fingolimod—Dizziness—Temozolomide—brain cancer	0.000368	0.00281	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—PTCH1—brain cancer	0.000365	0.00162	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—SMO—brain cancer	0.000365	0.00162	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP2C9—brain cancer	0.000365	0.00161	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STRADA—brain cancer	0.000363	0.00161	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—BSG—brain cancer	0.000361	0.0016	CbGpPWpGaD
Fingolimod—Headache—Carmustine—brain cancer	0.000361	0.00276	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—IDH1—brain cancer	0.000359	0.00159	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—TRPC6—brain cancer	0.000358	0.00158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—TRPC6—brain cancer	0.000358	0.00158	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—TRPC6—brain cancer	0.000358	0.00158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—SMO—brain cancer	0.000352	0.00156	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PTCH1—brain cancer	0.000352	0.00156	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PTCH1—brain cancer	0.000352	0.00156	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—SMO—brain cancer	0.000352	0.00156	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.00035	0.00155	CbGpPWpGaD
Fingolimod—Headache—Temozolomide—brain cancer	0.000349	0.00267	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ABR—brain cancer	0.000347	0.00153	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000345	0.00153	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTCH2—brain cancer	0.000342	0.00151	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—SHH—brain cancer	0.000337	0.00149	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GLI2—brain cancer	0.000335	0.00148	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ABR—brain cancer	0.000334	0.00148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ABR—brain cancer	0.000334	0.00148	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HES5—brain cancer	0.000331	0.00147	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—TRPC6—brain cancer	0.000325	0.00144	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GLI2—brain cancer	0.000322	0.00143	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GLI2—brain cancer	0.000322	0.00143	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STRADA—brain cancer	0.000322	0.00142	CbGpPWpGaD
Fingolimod—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00032	0.00142	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—SMO—brain cancer	0.000319	0.00141	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PTCH1—brain cancer	0.000319	0.00141	CbGpPWpGaD
Fingolimod—Asthenia—Etoposide—brain cancer	0.000319	0.00244	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—GLI1—brain cancer	0.000315	0.00139	CbGpPWpGaD
Fingolimod—Pruritus—Etoposide—brain cancer	0.000315	0.00241	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—IDH1—brain cancer	0.00031	0.00137	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—BSG—brain cancer	0.00031	0.00137	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—VAV1—brain cancer	0.000307	0.00136	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000306	0.00135	CbGpPWpGaD
Fingolimod—Diarrhoea—Etoposide—brain cancer	0.000305	0.00233	CcSEcCtD
Fingolimod—CYP2D6—brain—brain cancer	0.000304	0.00169	CbGeAlD
Fingolimod—S1PR3—Signaling Pathways—GLI1—brain cancer	0.000303	0.00134	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ABR—brain cancer	0.000303	0.00134	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GLI1—brain cancer	0.000303	0.00134	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SUFU—brain cancer	0.000299	0.00132	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—VAV1—brain cancer	0.000295	0.00131	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—VAV1—brain cancer	0.000295	0.00131	CbGpPWpGaD
Fingolimod—Dizziness—Etoposide—brain cancer	0.000294	0.00225	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—GLI2—brain cancer	0.000293	0.0013	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GFAP—brain cancer	0.000288	0.00127	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SUFU—brain cancer	0.000287	0.00127	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SUFU—brain cancer	0.000287	0.00127	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ENO2—brain cancer	0.000284	0.00126	CbGpPWpGaD
Fingolimod—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000284	0.00126	CbGpPWpGaD
Fingolimod—Headache—Etoposide—brain cancer	0.000279	0.00213	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—VAV1—brain cancer	0.000279	0.00123	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GFAP—brain cancer	0.000277	0.00123	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GFAP—brain cancer	0.000277	0.00123	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GLI1—brain cancer	0.000275	0.00122	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HEY1—brain cancer	0.000273	0.00121	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ABR—brain cancer	0.000268	0.00119	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—VAV1—brain cancer	0.000268	0.00119	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—VAV1—brain cancer	0.000268	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—VAV1—brain cancer	0.000268	0.00119	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DLL1—brain cancer	0.000268	0.00119	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—IDH1—brain cancer	0.000267	0.00118	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HEY1—brain cancer	0.000263	0.00116	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HEY1—brain cancer	0.000263	0.00116	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SUFU—brain cancer	0.000261	0.00115	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GLI2—brain cancer	0.000259	0.00115	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DLL1—brain cancer	0.000258	0.00114	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DLL1—brain cancer	0.000258	0.00114	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000253	0.00112	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GFAP—brain cancer	0.000252	0.00111	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000248	0.0011	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ENO2—brain cancer	0.000245	0.00109	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000245	0.00108	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GLI1—brain cancer	0.000244	0.00108	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—VAV1—brain cancer	0.000243	0.00108	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HEY1—brain cancer	0.000239	0.00106	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DLL1—brain cancer	0.000234	0.00104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SUFU—brain cancer	0.000231	0.00102	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SHH—brain cancer	0.000228	0.00101	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GFAP—brain cancer	0.000223	0.000986	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TRPC6—brain cancer	0.00022	0.000972	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SHH—brain cancer	0.000219	0.00097	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SHH—brain cancer	0.000219	0.00097	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000217	0.00096	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTCH1—brain cancer	0.000216	0.000955	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SMO—brain cancer	0.000216	0.000955	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TRPC6—brain cancer	0.000211	0.000935	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TRPC6—brain cancer	0.000211	0.000935	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HEY1—brain cancer	0.000211	0.000935	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ENO2—brain cancer	0.000211	0.000932	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMO—brain cancer	0.000208	0.00092	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTCH1—brain cancer	0.000208	0.00092	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTCH1—brain cancer	0.000208	0.00092	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMO—brain cancer	0.000208	0.00092	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DLL1—brain cancer	0.000207	0.000917	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SHH—brain cancer	0.000199	0.000881	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CG—brain cancer	0.000195	0.000862	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TRPC6—brain cancer	0.000192	0.000849	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SMO—brain cancer	0.000189	0.000835	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTCH1—brain cancer	0.000189	0.000835	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CG—brain cancer	0.000187	0.000829	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CG—brain cancer	0.000187	0.000829	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CG—brain cancer	0.000177	0.000783	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SHH—brain cancer	0.000176	0.00078	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOTCH2—brain cancer	0.000173	0.000764	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CG—brain cancer	0.00017	0.000753	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CG—brain cancer	0.00017	0.000753	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CG—brain cancer	0.00017	0.000753	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TRPC6—brain cancer	0.00017	0.000752	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTCH1—brain cancer	0.000167	0.000739	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMO—brain cancer	0.000167	0.000739	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOTCH2—brain cancer	0.000166	0.000735	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOTCH2—brain cancer	0.000166	0.000735	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VAV1—brain cancer	0.000165	0.000728	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000162	0.000718	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00016	0.000708	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VAV1—brain cancer	0.000158	0.000701	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VAV1—brain cancer	0.000158	0.000701	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CG—brain cancer	0.000155	0.000684	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH2—brain cancer	0.000151	0.000668	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VAV1—brain cancer	0.000144	0.000636	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HES1—brain cancer	0.000142	0.000626	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—brain cancer	0.000137	0.000606	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HES1—brain cancer	0.000136	0.000603	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HES1—brain cancer	0.000136	0.000603	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PDGFRA—brain cancer	0.000135	0.000596	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH2—brain cancer	0.000134	0.000591	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—brain cancer	0.000132	0.000584	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—brain cancer	0.000132	0.000584	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SPP1—brain cancer	0.000131	0.000579	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CG—brain cancer	0.00013	0.000577	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PDGFRA—brain cancer	0.00013	0.000574	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PDGFRA—brain cancer	0.00013	0.000574	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—brain cancer	0.000127	0.000564	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VAV1—brain cancer	0.000127	0.000563	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SPP1—brain cancer	0.000126	0.000557	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SPP1—brain cancer	0.000126	0.000557	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2—brain cancer	0.000124	0.000551	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HES1—brain cancer	0.000124	0.000547	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—brain cancer	0.00012	0.00053	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2—brain cancer	0.00012	0.00053	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—brain cancer	0.00012	0.00053	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IRS2—brain cancer	0.000118	0.000523	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PDGFRA—brain cancer	0.000118	0.000521	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SPP1—brain cancer	0.000114	0.000506	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IRS2—brain cancer	0.000114	0.000504	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IRS2—brain cancer	0.000114	0.000504	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CG—brain cancer	0.000112	0.000498	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HES1—brain cancer	0.000109	0.000484	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—brain cancer	0.000109	0.000481	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APC—brain cancer	0.000104	0.000462	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CG—brain cancer	0.000104	0.000462	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PDGFRA—brain cancer	0.000104	0.000461	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IRS2—brain cancer	0.000103	0.000458	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SPP1—brain cancer	0.000101	0.000448	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CG—brain cancer	0.000101	0.000445	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APC—brain cancer	0.000101	0.000445	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APC—brain cancer	0.000101	0.000445	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CG—brain cancer	0.000101	0.000445	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CG—brain cancer	9.66e-05	0.000428	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—brain cancer	9.52e-05	0.000421	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—brain cancer	9.16e-05	0.000405	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—brain cancer	9.16e-05	0.000405	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IRS2—brain cancer	9.15e-05	0.000405	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APC—brain cancer	9.13e-05	0.000404	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CG—brain cancer	9.13e-05	0.000404	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—brain cancer	8.32e-05	0.000368	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RELA—brain cancer	8.16e-05	0.000361	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—brain cancer	8.11e-05	0.000359	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CG—brain cancer	8.08e-05	0.000358	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APC—brain cancer	8.08e-05	0.000358	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RELA—brain cancer	7.86e-05	0.000348	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RELA—brain cancer	7.86e-05	0.000348	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—brain cancer	7.81e-05	0.000346	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—brain cancer	7.81e-05	0.000346	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—brain cancer	7.35e-05	0.000325	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—brain cancer	7.17e-05	0.000317	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RELA—brain cancer	7.14e-05	0.000316	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—brain cancer	7.1e-05	0.000314	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—brain cancer	7.09e-05	0.000314	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—brain cancer	7.08e-05	0.000313	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—brain cancer	7.08e-05	0.000313	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—brain cancer	6.9e-05	0.000305	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—brain cancer	6.9e-05	0.000305	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—brain cancer	6.83e-05	0.000302	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—brain cancer	6.83e-05	0.000302	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—brain cancer	6.43e-05	0.000284	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RELA—brain cancer	6.31e-05	0.000279	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—brain cancer	6.27e-05	0.000278	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—brain cancer	6.26e-05	0.000277	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—brain cancer	6.25e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—brain cancer	6.2e-05	0.000274	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—brain cancer	6.19e-05	0.000274	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—brain cancer	6.01e-05	0.000266	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—brain cancer	6.01e-05	0.000266	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2C9—brain cancer	5.98e-05	0.000265	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—brain cancer	5.95e-05	0.000263	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—brain cancer	5.95e-05	0.000263	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—brain cancer	5.75e-05	0.000254	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—brain cancer	5.69e-05	0.000252	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—brain cancer	5.62e-05	0.000249	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—brain cancer	5.54e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—brain cancer	5.53e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—brain cancer	5.53e-05	0.000245	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—brain cancer	5.49e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—brain cancer	5.46e-05	0.000242	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—brain cancer	5.41e-05	0.000239	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—brain cancer	5.41e-05	0.000239	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—brain cancer	5.41e-05	0.000239	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BSG—brain cancer	5.09e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—brain cancer	5.02e-05	0.000222	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—brain cancer	4.91e-05	0.000217	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—brain cancer	4.83e-05	0.000214	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—brain cancer	4.79e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—brain cancer	4.72e-05	0.000209	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—brain cancer	4.54e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—brain cancer	4.54e-05	0.000201	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—brain cancer	4.45e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—IDH1—brain cancer	4.38e-05	0.000194	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—brain cancer	4.35e-05	0.000192	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2C9—brain cancer	4.25e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—brain cancer	4.13e-05	0.000183	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—brain cancer	3.65e-05	0.000162	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BSG—brain cancer	3.61e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—brain cancer	3.46e-05	0.000153	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—IDH1—brain cancer	3.1e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2C9—brain cancer	2.78e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—brain cancer	2.45e-05	0.000109	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BSG—brain cancer	2.36e-05	0.000104	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—IDH1—brain cancer	2.03e-05	8.98e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—brain cancer	1.6e-05	7.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—brain cancer	1.59e-05	7.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—brain cancer	1.13e-05	4.98e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—brain cancer	7.36e-06	3.26e-05	CbGpPWpGaD
